Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Iscar for Supplemental Care in Stage IV Lung Cancer

NCT00079794 is registered in ClinicalTrials.gov with National Center for Complementary and Integrative Health (NCCIH) as lead sponsor.

NCT NCT00079794
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00079794 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Iscar for Supplemental Care in Stage IV Lung Cancer
Lead sponsor
National Center for Complementary and Integrative Health (NCCIH)
Phase
Phase 2
Overall status
Completed
Start date
September 30, 2001
Completion date
February 29, 2004
Enrollment
36
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer